RCEL:NASDAQ
AVITA Medical Inc
US$ 13.14
arrow_upward
+0.77%(+0.10) Siku 1
US$ 13.14
0.00% (0.00)
bedtimeBaada ya saa
Imefungwa: 19 Okt, 16:00:01 GMT -4 · USD
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya RCEL...
Fungua
US$ 13.01
Juu
US$ 13.44
Chini
US$ 12.70
Mtaji wa soko
406.38M
Wastani wa kiasi cha mauzo
elfu 323.00
Kiasi cha mauzo ya hisa
elfu 267.14
Juu kwa wiki 52
US$ 13.73
Chini kwa wiki 52
US$ 3.22
EPS
-US$ 1.44
Beta
1.99
Hisa za wawekezaji
30.93M
Idadi ya wafanyakazi
226
Fungua
US$ 13.01
Juu
US$ 13.44
Chini
US$ 12.70
Mtaji wa soko
406.38M
Wastani wa kiasi cha mauzo
elfu 323.00
Kiasi cha mauzo ya hisa
elfu 267.14
Juu kwa wiki 52
US$ 13.73
Chini kwa wiki 52
US$ 3.22
EPS
-US$ 1.44
Beta
1.99
Hisa za wawekezaji
30.93M
Idadi ya wafanyakazi
226
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
Simply Wall Street
·
saa 9 zilizopita
What Comes Next For AVITA Medical After A 276% Gain
ad-hoc-news.de
·
siku 1 iliyopita
BTIG raises target for Avita Medical stock from USD 11.00 to USD 15.00
Wasifu
Avita Medical is a clinical and commercial company developing and marketing a range of regenerative medicine products. The first regenerative medicine product brought to the market by Avita Medical was ReCell spray-on skin for the treatment of burns. The two latest products are PermeaDerm, a transparent, biosynthetic bilayer wound matrix used for temporary wound coverage after surgical excision of burns or trauma, and Cohealyx, a bovine-derived collagen dermal matrix used by burn and trauma surgeons to treat severe wounds and full-thickness burns by accelerating blood vessel formation in order to prepare damaged wound beds for skin autografts. Wikipedia
Kuhusu AVITA Medical Inc
Afisa Mkuu Mtendaji (CEO)James Corbett
Wafanyakazi226
Lilianzishwa1999
Makao makuuValencia, California, Marekani
Sekta-
Tovutiavitamedical.com